title: Critical coronary artery stenosis and aortitis in a patient with relapsing polychondritis.
authors.forename: Jonathan D
authors.initials: JD
authors.lastname: Stein
authors.forename: Peter
authors.initials: P
authors.lastname: Lee
authors.forename: Bindee
authors.initials: B
authors.lastname: Kuriya
authors.forename: Jerry
authors.initials: J
authors.lastname: Tenenbaum
authors.forename: Lorretta B
authors.initials: LB
authors.lastname: Daniel
authors.forename: Jagdish
authors.initials: J
authors.lastname: Butany
authors.forename: Yves L
authors.initials: YL
authors.lastname: Provost
authors.forename: Tyrone E
authors.initials: TE
authors.lastname: David
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D001025:Aortitis / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D006348:Cardiac Surgical Procedures; D003131:Combined Modality Therapy; D023921:Coronary Stenosis / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005080:Exercise Test; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D011081:Polychondritis, Relapsing / Q000150:complications / Q000175:diagnosis* / Q000628:therapy; D011241:Prednisone / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011241:Prednisone; D008727:Methotrexate